Knocksense: A local content and recommendations platform

{{ subpage.title }}

Lucknow's CDRI finds success in clinical trials of a new drug to be used for treating COVID

In a remarkable breakthrough, Lucknow's Central Drug Research Institute (CDRI) announced the success of clinical trials for Umifenovir, an antiviral drug to be used in the treatment of COVID-19. As per the study conducted on 132 COVID patients, proper doses of the drug, administered twice daily for a period of five days, can ensure significant results. It has been claimed that the drug can lower viral load to zero in mild or moderate symptomatic and asymptomatic patients.

Read Now Show less

Newly introduced Roche's antibody-drug to aid patients by reducing viral infectivity

Augmenting the range of medical resources available for the treatment of COVID patients, Roche India introduced the first set of antibody cocktail (Casirivimab and Imdevimab) against Coronavirus. Open for distribution through an announcement on Monday, the cocktail drug will be retailed by Cipla across all regions of India. It is expected that the second batch will be brought to the market by mid-June, benefitting a large count of affected patients.

Read Now Show less

DRDO crafted anti-infection drug to expedite recovery & reduce oxygen dependence!

In a moment of relief, the first stock of DRDO-crafted anti-COVID drug, 2-DG (2-deoxy-D-glucose) was flagged off earlier this week, for COVID affected individuals. Developed by associative efforts of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO) and Dr Reddy's Laboratories (DRL), the first consignment of the drug was made public amidst the esteemed presence of Defence Minister and Health Minister.

Read Now Show less